Currently Viewing:
Newsroom
Currently Reading
Headache Disorders Play Significant Role in Disability Globally and Require More Attention, Study Finds
December 12, 2018 – Alison Rodriguez
Pennsylvania Auditor General Calls for Action on PBMs
December 12, 2018 – Allison Inserro
Diet Has Minimal Association With Breast Cancer Risk in Postmenopausal Women, Study Finds
December 12, 2018 – David Bai, PharmD
Myelofibrosis Survival After Discontinuing Ruxolitinib Differs Based on Reason for Discontinuation
December 12, 2018 – Jaime Rosenberg
What We're Reading: Bill Targets Maternal Mortality Rates; Cutting Drug Prices; US Biosimilar Adoption
December 12, 2018 – AJMC Staff
What We're Reading: High Court Lets Abortion Cases Stand; NIH and Fetal Tissue; Dsuvia Examined
December 11, 2018 – AJMC Staff
Durvalumab Combination Fails to Meet Primary End Point in NSCLC Trial
December 11, 2018 – Samantha DiGrande
Rate of Uninsured Increased in 2017 for the First Time Since 2014
December 11, 2018 – Allison Inserro
More Than 300 Groups Seek Halt to CMS' Plans for Global Drug Pricing Index
December 10, 2018 – Allison Inserro

Shared Decision-Making Tool Can Identify Best Treatment Plan for Patients With Severe Asthma

Laura Joszt
New tools from the American College of Chest Physicians' CHEST Foundation, the Allergy & Asthma Network, and the American College of Allergy, Asthma & Immunology can help clinicians and patients to work together to choose the best treatment and increase adherence.
A new tool can be used by clinicians and patients to determine the best treatment for patients with severe asthma. The Shared Decision-Making Tool is the result of a collaboration between the CHEST Foundation—the charitable foundation of the American College of Chest Physicians—the Allergy & Asthma Network, and the American College of Allergy, Asthma & Immunology (ACAAI).

Asthma affects 1 in 12 adults and 1 in 11 children in the United States for a total of 22 million Americans. It affects females more than males (9.7% vs 6.9%) and blacks more than whites (11.6% vs 8.3%) or Hispanics (6.6%), according to 2016 data from the CDC. However, as a subset of Hispanics, Puerto Ricans were more affected, with 14.3% having asthma.

“The tool is a step forward in helping direct the conversation between allergists and their patients with asthma,” allergist Bradley Chipps, MD, president of ACAAI, said in a statement. “Fully informed conversations regarding asthma treatment mean greater asthma control and ultimately increased relief for those suffering with asthma.”

According to the press release, some patients with asthma believe their condition is well controlled, which can be a dangerous misconception. The Shared Decision-Making Tool is supposed to shed light on the importance of self-management, shared decision making, and the importance of knowing the difference between controlled and uncontrolled asthma.

The tool is available online and in print and can help patients and clinicians to work together to choose the best treatment plan and increase adherence.

The partnership has also yielded another tool, which can be used to improve patient awareness and monitor and manage asthma symptoms. The Asthma Severity Assessment Tool can determine if a patient needs to visit an asthma specialist.

“We hope these tools will arm patients with the knowledge needed to talk effectively with doctors about their asthma and empower them to achieve optimal health outcomes,” said Tonya Winders, president and CEO of the Allergy & Asthma Network.

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!